Spatial Omics is changing how we understand disease

The human body is composed of 37 trillion cells, working together in ways that remains one of biology’s greatest mysteries. Emerging technologies collectively known as “spatial omics” offer researchers a groundbreaking approach to unravel this puzzle.

By allowing scientists to examine the precise location and interaction of molecules within tissues, these technologies provide unprecedented insights into the inner workings of diseases.

Spatial omics is already transforming patient care. For example, in an international collaboration led by the Max Planck Institute of Biochemistry, scientists repurposed JAK inhibitors for toxic epidermal necrolysis, significantly improving outcomes for the patients involved in the study.

In addition, major initiatives, like our MOSAIC (Multi-Omics Spatial Atlas In Cancer) study, are creating the large scale spatial and multiomics datasets and the AI models that are needed to fuel clinically relevant discoveries.